Related references
Note: Only part of the references are listed.Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma
Fernanda I. Staquicini et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study
Sabine Mueller et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Selection of phage-displayed peptides on live adherent cells in microfluidic channels
Jinpeng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Poor drug distribution as a possible explanation for the results of the PRECISE trial Clinical article
John H. Sampson et al.
JOURNAL OF NEUROSURGERY (2010)
Dual Integrin and Gastrin-Releasing Peptide Receptor Targeted Tumor Imaging Using 18F-labeled PEGylated RGD-Bombesin Heterodimer 18F-FB-PEG3-Glu-RGD-BBN
Zhaofei Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
Achuthamangalam B. Madhankumar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy
Jill Wykosky et al.
CLINICAL CANCER RESEARCH (2008)
Peptide-Based Probes for Cancer Imaging
Jean Claude Reubi et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Noninvasive assessment of cancer response to therapy
Zhaozhong Han et al.
NATURE MEDICINE (2008)
Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines
Ronald J. Bernardi et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
From combinatorial chemistry to cancer-targeting peptides
Olulanu H. Aina et al.
MOLECULAR PHARMACEUTICS (2007)
Interleukin-13 receptor α2 chain -: A potential biomarker and molecular target for ovarian cancer therapy
Mitomu Kioi et al.
CANCER (2006)
IL-13 signaling through the IL-13 alpha 2 receptor is involved in induction of TGF-beta 1 production and fibrosis
S Fichtner-Feigl et al.
NATURE MEDICINE (2006)
Gene expression profiling identifies IL-13 receptor α2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin
O Gonzalez-Moreno et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13R alpha 2
AB Madhankumar et al.
NEOPLASIA (2004)
Molecular targeting with recombinant cytotoxins of interleukin-13 receptor α2-expressing glioma
A Mintz et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
IL-13 receptors and signaling pathways: An evolving web
GKK Hershey
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Alanine-scanning mutagenesis of α-helix D segment of interleukin 13 reveals new functionally important residues of the cytokine
AB Madhankumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor cell-targeting by phage-displayed peptides
UB Rasmussen et al.
CANCER GENE THERAPY (2002)
Expression of interleukin 13 receptor in glioma and renal cell carcinoma:: IL13Rα2 as a decoy receptor for IL13
J Bernard et al.
LABORATORY INVESTIGATION (2001)
Share Paper
